An understanding of the sublethal effects of pesticide residues on phytoseiid mites is important to successful augmentation and conservation programs. We assessed the residual and sublethal effects of four concentrations of fenpyroximate (LC5, LC10, LC20 and LC30) and three concentrations of abamectin (LC10, LC20 and LC30) on prey consumption rates of exposed females of Phytoseius plumifer (Canestrini & Fanzago) and their offspring when fed Tetranychus urticae Koch. Prey consumption of female mites was strongly affected by treatment with all concentrations of the two acaricides. Throughout the study, females exposed to fenpyroximate showed a more extreme reduction in prey consumption than those exposed to abamectin. In contrast, abamectin affected the prey consumption of the subsequent generation of females to a greater extent than fenpyroximate. Of the subsequent generation, total protonymphal and total nymphal prey consumption were adversely affected by both acaricide treatments at the highest concentration. Deutonymph prey consumption of fenpyroximate exposed females was reduced, but not of abamectin exposed ones. Total nymphal offspring prey consumption did not significantly differ between the two acaricide treatments. In conclusion, use of either acaricide decreased the predation rate of P. plumifer, and this effect should be considered when designing integrated management programs.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.